Literature DB >> 4211925

Differences in acute and convalescent-phase antibodies of cats infected with feline picornaviruses.

R G Olsen, D E Kahn, E A Hoover, N J Saxe, D S Yohn.   

Abstract

Complement fixation inhibiting and complement-fixing antibodies were demonstrated in sera from cats during the acute and convalescent stages, respectively, of feline picornavirus infections. Complement-fixing antibody activity was present in 19S and 7S globulins, whereas complement fixation inhibiting antibody activity was confined to the 7S globulins. Sera with complement-fixing antibody and sera with complement fixation inhibiting antibody were also shown to have neutralizing and precipitating antibodies. In a study of antibody responses to homotypic and heterotypic strains of feline picornavirus, less serological cross-reactions were observed between strains of feline picornavirus in sera from cats in the acute phase of feline picornavirus infection than in the convalescent phase. The temporal relationship of complement fixation inhibiting and complement-fixing antibody responses of cats after acute viral respiratory infections is contrasted with previously observed antibody response in cats to feline leukemia virus.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4211925      PMCID: PMC415008          DOI: 10.1128/iai.10.2.375-380.1974

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  Demonstration of antibody in cat sera to feline oncornavirus by complement-fixation inhibition.

Authors:  R G Olsen; D S Yohn
Journal:  J Natl Cancer Inst       Date:  1972-08       Impact factor: 13.506

2.  The germfree cat.

Authors:  M W Rohovsky; R A Griesemer; L G Wolfe
Journal:  Lab Anim Care       Date:  1966-02

3.  Feline viruses: pathogenesis of picornavirus infection in the cat.

Authors:  D E Kahn; J H Gillespie
Journal:  Am J Vet Res       Date:  1971-04       Impact factor: 1.156

4.  Feline viruses. X. Characterization of a newly-isolated picornavirus causing interstitial pneumonia and ulcerative stomatitis in the domestic cat.

Authors:  D E Kahn; J H Gillespie
Journal:  Cornell Vet       Date:  1970-10

5.  Pathologic features of picornavirus infections in cats.

Authors:  E A Holzinger; D E Kahn
Journal:  Am J Vet Res       Date:  1970-09       Impact factor: 1.156

6.  The complement-fixation reaction in eguine infectious anemia: demonstration of inhibition by IgG (T).

Authors:  T C McGuire; G L Van Hoosier; J B Henson
Journal:  J Immunol       Date:  1971-12       Impact factor: 5.422

7.  Requirement of thymus-dependent lymphocytes for potentiation by adjuvants of antibody formation.

Authors:  A C Allison; A J Davies
Journal:  Nature       Date:  1971-10-01       Impact factor: 49.962

8.  Oncogenes of RNA tumor viruses as determinants of cancer.

Authors:  R J Huebner; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1969-11       Impact factor: 11.205

9.  Immunodiffusion analysis of Yaba poxvirus structural and associated antigens.

Authors:  R G Olsen; D S Yohn
Journal:  J Virol       Date:  1970-02       Impact factor: 5.103

10.  Cell-to-cell interaction in the immune response. IX. Regulation of hepten-specific antibody class by carrier priming.

Authors:  C Cheers; J F Miller
Journal:  J Exp Med       Date:  1972-12-01       Impact factor: 14.307

View more
  4 in total

1.  Cross-protection among feline caliciviruses.

Authors:  C Povey; J Ingersoll
Journal:  Infect Immun       Date:  1975-05       Impact factor: 3.441

2.  Induction of immunity to feline caliciviral disease.

Authors:  D E Kahn; E A Hoover; J L Bittle
Journal:  Infect Immun       Date:  1975-05       Impact factor: 3.441

3.  The capsid gene of feline calicivirus contains linear B-cell epitopes in both variable and conserved regions.

Authors:  A D Radford; K Willoughby; S Dawson; C McCracken; R M Gaskell
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

4.  Modified-Live Feline Calicivirus Vaccination Reduces Viral RNA Loads, Duration of RNAemia, and the Severity of Clinical Signs after Heterologous Feline Calicivirus Challenge.

Authors:  Andrea M Spiri; Barbara Riond; Martina Stirn; Marilisa Novacco; Marina L Meli; Felicitas S Boretti; Imogen Herbert; Margaret J Hosie; Regina Hofmann-Lehmann
Journal:  Viruses       Date:  2021-07-30       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.